What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options

Breast Cancer. 2023 Mar;30(2):187-199. doi: 10.1007/s12282-022-01428-z. Epub 2022 Dec 26.

Abstract

Breast-cancer-related lymphedema (BCRL) is a common consequence of oncological treatment. Its management is a complicated, chronic, and arduous process. Therapeutic options can be divided on non-surgical and surgical methods, although there is still no clear consensus about their effectiveness in preventing or stopping the disease. That brings problems in everyday practice, as there are no guidelines about proper time for starting therapy and no agreement about which management will be beneficial for each patient. The aim of this review is to summarize current knowledge about possible treatment choices, non-surgical so as surgical, indicate knowledge gaps, and try to direct pathways for future studies.

Keywords: Breast cancer; Lymphedema; Prevention; Treatment.

Publication types

  • Review

MeSH terms

  • Breast Cancer Lymphedema* / etiology
  • Breast Cancer Lymphedema* / therapy
  • Breast Neoplasms* / complications
  • Breast Neoplasms* / therapy
  • Female
  • Humans
  • Lymphedema* / prevention & control
  • Lymphedema* / therapy